Digital diagnosis and treatment system for sarcopenia
Establishment and Application of a Digital Diagnosis and Treatment System for Sarcopenia
This study is testing a new digital system to help diagnose and treat sarcopenia in people aged 45 and older by providing early screening, medication, and rehabilitation programs tailored to their needs.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 45 Years and up |
| Sex | All |
| Sponsor | Peking Union Medical College Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT06380777 on ClinicalTrials.gov |
What this trial studies
This observational study aims to establish a comprehensive digital system for diagnosing and treating sarcopenia. It integrates a digital vaccine for early screening, a digital drug for intervention, and a digital rehabilitation program for prevention. Participants aged 45 and older will be screened and monitored longitudinally, receiving tailored interventions based on their condition. The study seeks to create a visual tertiary prevention network to effectively manage sarcopenia.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 45 and older who meet the diagnostic criteria for sarcopenia.
Not a fit: Patients under 45 years old or those with acute chronic illnesses or cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve early detection and management of sarcopenia, enhancing patient outcomes.
How similar studies have performed: While the integration of digital tools in managing sarcopenia is innovative, similar approaches in other conditions have shown promise, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥45 years; * meeting sarcopenia diagnostic criteria; * consent to participate in this study Exclusion Criteria: * Age \<45 years; * patients in acute phase of chronic illness; * infectious disease patients; * people who lack of independent mobility; * people who lack of communication or cognitive skills; * people who refusal to participate in this study
Where this trial is running
Beijing, Beijing Municipality
- Peking Union Medical College Hospital — Beijing, Beijing Municipality, China (Recruiting)
Study contacts
- Study coordinator: Yu Kang
- Email: yuk1997@sina.com
- Phone: 86 13801130457
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.